Investigator-Initiated vs. Investigator-Sponsored Research: Definitions Matter

被引：2
|
作者：
Paleoudis, Elli Gourna [1 ,2 ]
Pinto, Cheryl [1 ]
机构：
[1] Hackensack Meridian Hlth Res Inst, Off Res Adm, Nutley, NJ 07110 USA
[2] Hackensack Meridian Sch Med, Dept Med Sci, Nutley, NJ USA
来源：
JOURNAL OF CLINICAL MEDICINE RESEARCH-CANADA | 2024年 / 16卷 / 01期
关键词：
D O I：
10.14740/jocmr5090
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：31 / 32
页数：2
相关论文
共 50 条
  • [31] Investigator-initiated trials of targeted oncology agents: why independent research is at risk?
    Bergmann, L.
    Berns, B.
    Dalgleish, A. G.
    von Euler, M.
    Hecht, T. T.
    Lappin, G. L.
    Reed, N.
    Palmeri, S.
    Smyth, J.
    Embacher-Aichorn, S.
    Zwierzina, H.
    ANNALS OF ONCOLOGY, 2010, 21 (08) : 1573 - 1578
  • [32] Compensation guidelines for research-related injury in India could destroy investigator-initiated research
    Pramesh, C. S.
    Badwe, Rajendra A.
    NATIONAL MEDICAL JOURNAL OF INDIA, 2012, 25 (01): : 35 - 37
  • [33] Sotatercept for anemia of myelofibrosis: a phase II investigator-initiated study
    Bose, Prithviraj
    Masarova, Lucia
    Pemmaraju, Naveen
    Bledsoe, Sharon D.
    Daver, Naval G.
    Jabbour, Elias J.
    Kadia, Tapan M.
    Estrov, Zeev
    Kornblau, Steven M.
    Andreeff, Michael
    Jain, Nitin
    Cortes, Jorge E.
    Borthakur, Gautam
    Alvarado, Yesid
    Richie, Mary Ann
    Dobbins, Mackenzie H.
    Mccrackin, Selene A.
    Zhou, Lingsha
    Pierce, Sherry A.
    Wang, Xuemei
    Pike, Allison M.
    Garcia-Manero, Guillermo
    Kantarjian, Hagop M.
    Verstovsek, Srdan
    HAEMATOLOGICA, 2024, 109 (08) : 2660 - 2664
  • [34] Investigator-initiated clinical trials conducted by the Portuguese Clinical Research Infrastructure Network (PtCRIN)
    Madeira, C.
    Pais, A.
    Kubiak, C.
    Demotes, J.
    Monteiro, E. C.
    CONTEMPORARY CLINICAL TRIALS COMMUNICATIONS, 2016, 4 : 141 - 148
  • [35] Feasibility of a Hybrid Risk-Adapted Monitoring System in Investigator-Sponsored Trials in Cancer
    Kim, Sinae
    Kim, YunJung
    Hong, YoungLan
    Kim, YunOk
    Lim, Joon Seo
    Lee, JiSung
    Kim, Tae Won
    THERAPEUTIC INNOVATION & REGULATORY SCIENCE, 2021, 55 (01) : 180 - 189
  • [36] Development, Review, and Activation of Thoracic Oncology Investigator-Initiated Trials
    Gerber, David E.
    Wynters, Claire R.
    Prasad, Tanushree
    Schnel, Ronny K.
    Zhang, Song
    Stinchcombe, Thomas E.
    Villaruz, Liza C.
    Bauml, Joshua M.
    Iams, Wade T.
    Patil, Tejas
    Liu, Stephen V.
    Horn, Leora
    Hudak, John M.
    Camidge, D. Ross
    CLINICAL CANCER RESEARCH, 2025, 31 (06) : 1103 - 1108
  • [37] Challenges for Academic Investigator-Initiated Pediatric Trials for Rare Diseases
    Ahmed, Raees
    Duerr, Ulrike
    Gavenis, Karsten
    Hilgers, Reinhard
    Gross, Oliver
    CLINICAL THERAPEUTICS, 2014, 36 (02) : 184 - 190
  • [38] Serious adverse event reporting in investigator-initiated clinical trials
    Wallace, Sophie
    Myles, Paul S.
    Zeps, Nikolajs
    Zalcberg, John R.
    MEDICAL JOURNAL OF AUSTRALIA, 2016, 204 (06) : 231 - +
  • [39] The value proposition of investigator-initiated clinical trials conducted by networks
    Tate, Rhiannon
    Britton, Emma
    Webb, Steve
    Ramage, Charlotte
    Bernhardt, Julie
    Cass, Alan
    French, Craig J.
    Groom, Katie
    Herkes, Robert
    Katz, Catherine
    Mol, Ben W.
    Simes, R. John
    Sonderlund, Neil
    Butcher, Belinda E.
    Zalcberg, John R.
    MEDICAL JOURNAL OF AUSTRALIA, 2021, 214 (04) : 159 - +
  • [40] How Everybody Wins When Playing by the Rules: The Benefits of Investigator-Initiated Industry-Sponsored Clinical Trials
    Brinjikji, W.
    Kallmes, D. F.
    AMERICAN JOURNAL OF NEURORADIOLOGY, 2011, 32 (03) : 427 - 429
12345